WEBULL
WebtradeDownload

BioMar Group (CPSE:BIOMAR) Stock Climbs As Record Volumes Meet Softer EPS

Simply Wall St · 1d ago

BioMar Group walked into this earnings week with a quietly rising share price, up about 9.7% over the past seven days and roughly 3.2% over the past month, which set expectations high. The headline from Q2 is simple: feed volumes reached record levels and earnings before interest and tax guidance lifted to DKK 1.2b to 1.3b for the year.

For an aquaculture feed specialist, that guidance shift and the record volumes are what really matter. Short term price excitement now has to be weighed against those fundamentals, not just the headline move on the day.

Is BioMar Group trading at a genuine discount to its DCF estimate, or does the P/E premium and debt profile tell a different story? See how that balance looks in our valuation analysis for BioMar Group

Q2 2026 Earnings Summary

  • Q2 2026 Revenue: 962 million DKK vs. Q2 2025 574 million DKK (up about 68%)
  • Q2 2026 Net Income (Excl. Extra Items): 101 million DKK vs. Q2 2025 105 million DKK (down about 4%)
  • Q2 2026 Basic EPS: 1.01 DKK vs. Q2 2025 1.05 DKK (down about 3%)
  • Trailing 12 Month Net Income (Excl. Extra Items): 706 million DKK for the 12 months to Q2 2026 vs. 675 million DKK for the 12 months to Q4 2024 (up about 5%)

Prefer clean charts instead of another wall of earnings figures and feed volume tables? See BioMar Group's full financial picture with a visual breakdown of its valuation in the company report for BioMar Group.

CPSE:BIOMAR Trailing 12-Month Earnings & Revenue History as at Aug 2026
CPSE:BIOMAR Trailing 12-Month Earnings & Revenue History as at Aug 2026

Record Volumes Support BioMar’s Growth Story

For investors leaning bullish on BioMar Group, the latest quarter gives some backing. Revenue reached DKK 962 million in Q2 2026 compared with DKK 574 million a year earlier, supported by record feed volumes and higher raw material prices. EBIT guidance is now DKK 1.2b to 1.3b for 2026, higher than before, and trailing 12 month net income is modestly higher at DKK 706 million. That combination of rising volumes, higher full year profit guidance and a solid return on invested capital above 23% points to a resilient, scaled aquaculture feed platform.

Margin Pressure And Cash Flow Keep Bears Engaged

The cautious view on BioMar Group also finds some support in these numbers. Q2 2026 net income excluding extra items eased to DKK 101 million from DKK 105 million and basic EPS slipped from DKK 1.05 to DKK 1.01, even with strong revenue. Shrimp volumes grew fast but EBIT per tonne weakened, which underlines margin sensitivity in more competitive segments and during toll milling in Ecuador. Operating cash flow was softer, with higher inventories and tax timing weighing. Raw material volatility linked to El Niño and biological risks remain front and center in management’s own risk list.

Review BioMar Group's margin sensitivity, debt load and biological exposure. Scan the independent risk analysis for BioMar Group which shows 1 important warning sign for potential hidden structural warning signs.

Stay Ahead With Simply Wall St

If BioMar Group's record feed volumes and updated EBIT guidance have your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for an entry point that fits your plan. After you own the stock, monitor your positions through the Portfolio Command Center so you cut through market noise and focus on the updates that matter most. For a longer term view, use the Community to see how other investors are thinking about risks, opportunities and portfolio fit. This way you can spot potential catalysts and warning signs early and stay a step ahead of the market.

Seeking Alternatives Beyond BioMar Group?

Fresh ideas often move first when momentum builds and potential breakouts are still under the radar for now. Do not get caught chasing what is already flying. Aim to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.